在这项临床研究中，研究人员收集了来源于复发难治性AML成人患者的T细胞，通过基因改造，使T细胞表面能够产生靶向CD123的嵌合抗原受体（CAR ...

Researchers at the University of Pennsylvania investigated the use of patient-derived anti-CD123 CAR T cells in treating ...

“Up to now, this study has provided important insights into the role of CD123-targeted allogeneic CAR-T therapy in relapsed refractory acute myeloid leukemia and the future development of our ...